BANGKOK : Thailand's state-owned oil firm PTT is set to expand further into pharmaceuticals as part of a consortium acquiring a unit of drugmaker Alvogen, the parent of Taiwan's Lotus Pharmaceutical, PTT said on Friday.
A consortium of PTT and Icelandic investment fund Aztiq have agreed a US$475 million purchase of Alvogen Emerging Markets Holdings Ltd, which holds a 57.48per cent stake in Lotus, according to Refinitiv Eikon.PTT said it will have a 37per cent indirect shareholding in Lotus - which makes drugs to treat cancer, cardiovascular disease and mental diseases - when the deal closes in the first quarter of 2022 and 60per cent of Adalvo.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: